PT1220667E - Beta-agonistas para tratar a endometriose ou a infertilidade ou para melhorar afertilidade - Google Patents

Beta-agonistas para tratar a endometriose ou a infertilidade ou para melhorar afertilidade

Info

Publication number
PT1220667E
PT1220667E PT00964272T PT00964272T PT1220667E PT 1220667 E PT1220667 E PT 1220667E PT 00964272 T PT00964272 T PT 00964272T PT 00964272 T PT00964272 T PT 00964272T PT 1220667 E PT1220667 E PT 1220667E
Authority
PT
Portugal
Prior art keywords
afertility
infertility
agonists
beta
improve
Prior art date
Application number
PT00964272T
Other languages
English (en)
Portuguese (pt)
Inventor
Howard L Levine
William J Bologna
Dominique De Ziegler
Original Assignee
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd
Publication of PT1220667E publication Critical patent/PT1220667E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PT00964272T 1999-10-05 2000-10-04 Beta-agonistas para tratar a endometriose ou a infertilidade ou para melhorar afertilidade PT1220667E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15775499P 1999-10-05 1999-10-05
US66838400A 2000-09-25 2000-09-25

Publications (1)

Publication Number Publication Date
PT1220667E true PT1220667E (pt) 2004-11-30

Family

ID=26854456

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00964272T PT1220667E (pt) 1999-10-05 2000-10-04 Beta-agonistas para tratar a endometriose ou a infertilidade ou para melhorar afertilidade

Country Status (28)

Country Link
EP (1) EP1220667B1 (https=)
JP (2) JP2003510354A (https=)
KR (1) KR100738724B1 (https=)
CN (1) CN1218694C (https=)
AR (1) AR028487A1 (https=)
AT (1) ATE271860T1 (https=)
AU (1) AU780736B2 (https=)
BR (1) BR0014548A (https=)
CA (1) CA2385974C (https=)
CO (1) CO5251423A1 (https=)
DE (1) DE60012554T2 (https=)
DK (1) DK1220667T3 (https=)
ES (1) ES2223581T3 (https=)
GE (1) GEP20043313B (https=)
HK (1) HK1044120B (https=)
HU (1) HU225990B1 (https=)
IL (2) IL148784A0 (https=)
MA (1) MA25501A1 (https=)
MX (1) MXPA02003453A (https=)
MY (1) MY129518A (https=)
NO (1) NO329663B1 (https=)
NZ (1) NZ518429A (https=)
PE (1) PE20010742A1 (https=)
PT (1) PT1220667E (https=)
TR (1) TR200200899T2 (https=)
TW (1) TWI280877B (https=)
UA (1) UA74168C2 (https=)
WO (1) WO2001024788A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
EP1872775A1 (en) 2006-06-29 2008-01-02 Polichem S.A. Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
EP3865502A1 (en) * 2010-03-22 2021-08-18 Allergan Pharmaceuticals International Limited Compositions and methods for non-toxic delivery of cdb-2914
KR101010031B1 (ko) * 2010-12-08 2011-01-21 류상범 흡수식 냉온수기용 엘리미네이터
SG11201407397WA (en) 2012-05-31 2014-12-30 Repros Therapeutics Inc Formulations and methods for vaginal delivery of antiprogestins
ES2688821T3 (es) 2012-11-02 2018-11-07 Repros Therapeutics Inc. Métodos y composiciones para tratar afecciones dependientes de la progesterona

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241087A (en) * 1979-04-02 1980-12-23 William H. Rorer, Inc. Dysmenorrhea treatment
NZ232801A (en) * 1989-03-07 1992-01-29 Adeza Biomedical Corp Diagnostic test for endometriosis
JP2602456B2 (ja) * 1990-04-12 1997-04-23 雪印乳業株式会社 子宮内膜症治療剤
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen

Also Published As

Publication number Publication date
ES2223581T3 (es) 2005-03-01
GEP20043313B (en) 2004-03-10
AU7525000A (en) 2001-05-10
JP2010018639A (ja) 2010-01-28
DE60012554D1 (de) 2004-09-02
TWI280877B (en) 2007-05-11
UA74168C2 (uk) 2005-11-15
IL148784A (en) 2006-12-31
DK1220667T3 (da) 2004-12-06
HK1044120B (en) 2004-12-17
ATE271860T1 (de) 2004-08-15
AU780736B2 (en) 2005-04-14
WO2001024788A2 (en) 2001-04-12
NO20021591D0 (no) 2002-04-04
BR0014548A (pt) 2002-06-04
DE60012554T2 (de) 2005-11-24
MY129518A (en) 2007-04-30
NO329663B1 (no) 2010-11-29
NZ518429A (en) 2004-02-27
KR20020062285A (ko) 2002-07-25
CN1218694C (zh) 2005-09-14
HUP0203050A3 (en) 2006-02-28
NO20021591L (no) 2002-05-28
HK1044120A1 (en) 2002-10-11
EP1220667A2 (en) 2002-07-10
IL148784A0 (en) 2002-09-12
WO2001024788A3 (en) 2001-12-06
HUP0203050A2 (hu) 2003-02-28
EP1220667B1 (en) 2004-07-28
CO5251423A1 (es) 2003-02-28
KR100738724B1 (ko) 2007-07-12
PE20010742A1 (es) 2001-07-19
HU225990B1 (en) 2008-02-28
CN1377264A (zh) 2002-10-30
TR200200899T2 (tr) 2002-07-22
MA25501A1 (fr) 2002-07-01
CA2385974A1 (en) 2001-04-12
CA2385974C (en) 2010-01-26
JP2003510354A (ja) 2003-03-18
MXPA02003453A (es) 2002-08-20
AR028487A1 (es) 2003-05-14

Similar Documents

Publication Publication Date Title
DE60109455D1 (de) Sicherheitsgurtsystem
DE60040454D1 (de) Lenkhilfsvorrichtung
DE60043707D1 (de) D regler
DE60007050D1 (de) IMC-Verfahren
DE60044002D1 (de) Sicherheitseinrichtung
DE50010717D1 (de) Rollenstössel
PT1220667E (pt) Beta-agonistas para tratar a endometriose ou a infertilidade ou para melhorar afertilidade
DE60133953D1 (de) Fahrzeug-Steuergerät
NO20020778L (no) Hydrosyklon
DE60002179D1 (de) Stossstange
DE50007312D1 (de) Sicherheitsventil
DE50013965D1 (de) Sicherungseinrichtung
DE50012254D1 (de) Zündeinrichtung
DE60013002D1 (de) Sicherheitsventil
DE60139709D1 (de) Datenbus
DE69909846D1 (de) Faltschachtel
DE60028867D1 (de) Verzögerungsleitung
NO994872D0 (no) Reisesafe
NO992762D0 (no) Sikkerhetsventil
DE50015688D1 (de) Pflastersteinsystem
DE60036655D1 (de) Langgestreckter Scheinwerfer
NO995371D0 (no) Sikkerhetsventil
DE59905993D1 (de) Abschaltkupplung
NO20004650D0 (no) Markeringer spesielt for mineralullprodukter
DK199900152U3 (da) Sandvasker